Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Serum Levels
46%
Inflammatory Lesions
46%
Neutrophil Extracellular Traps
46%
M2BPGi
46%
Microscopic Study
46%
Left Main Coronary Artery
46%
Cardiac Function Failure
46%
Anchorage-independent Aggregation
46%
SAS Cell
46%
Fatty Acid Binding Protein 4 (FABP4)
46%
Superficial Duodenal Epithelial Tumor
46%
Guanylate Cyclase
46%
Prenatal Ultrasound
46%
Non-ampullary Duodenal Adenocarcinoma
46%
Segmental Dilatation
46%
Adenylate Cyclase
46%
Lipolysis
46%
Adipocyte
46%
Protein Kinase G
46%
Genotoxicity
46%
Salivary Duct Carcinoma
46%
Resistance Acquisition
46%
Ki-67 Expression
46%
Cholesteatoma
46%
Cytokeratin 17
46%
Cytokeratin 13
46%
Acquired Cholesteatoma
46%
Coronary Perfusion
46%
Serum Creatine Kinase
46%
Method Development
46%
Chromogenic in Situ Hybridization
46%
Hepatic Fibrosis
46%
Pegylated Interferon
46%
Myoepithelial Carcinoma
46%
Omega-3-acid Ethyl Esters
46%
Fibrosis Marker
46%
Glioneuronal Tumor
46%
FGFR1 mutation
46%
Aortitis Syndrome
46%
Mixed Morphology
46%
Coronary Dilatation
46%
Anastomosis
46%
Hyaline Casts
46%
Risk Classification
46%
KDIGO
46%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
46%
Canagliflozin
46%
General Practice
46%
Febuxostat
46%
Ribavirin
46%
Morule
46%
FVPTC
46%
Cytohistology
46%
Transcatheter Intervention
46%
Graduate School Education
46%
Chronic Hepatitis C
46%
Bronchial Artery
46%
Heart-type Fatty Acid-binding Protein (H-FABP)
46%
Myoglobin
46%
Panel Test
46%
Acute Chest Syndrome
46%
Short-chain Fatty Acids Production
46%
COVID-19 Vaccine
46%
Mannose
46%
Significant Coronary Artery Disease
46%
Coronary Computed Tomography Angiography
46%
Regulatory T Cells
46%
Indoleamine 2,3-dioxygenase 2
46%
Partial Hepatectomy
46%
Fingertip Blood
46%
CD8+ Tregs
46%
Liver Regeneration
46%
Image Sampling
46%
CD8+ Regulatory T Cells
46%
Blood Vessel Images
46%
HSV-TK
46%
Autoanalyzer
46%
Red Blood Cell Parameters
46%
UF-5000
46%
Urine Particles
46%
Consistency Analysis
46%
Particle Analyzer
46%
Echocardiographic Parameters
46%
Information Systems Applications
46%
Martin Method
46%
Laboratory Information System
46%
Autoimmune Hepatitis
46%
Analytical Validation
46%
Fingerstick Blood
46%
Multi-face
46%
Whole-field
38%
Coronavirus Disease 2019 Vaccine
37%
Cribriform-morular Variant
35%
KO Mice
31%
Liver Fibrosis
29%
Acceptance Limits
28%
Antiretroviral Therapy
23%
Echogenic
23%
Sustained Virological Response
23%
Aortic Regurgitation
23%
Medicine and Dentistry
Neoplasm
96%
Brain Natriuretic Peptide
93%
Amino Terminal Sequence
93%
Long Untranslated RNA
93%
Blood Sampling
93%
Heart Failure
75%
Diagnosis
62%
Biological Marker
55%
Interferon
54%
Acute Decompensated Heart Failure
51%
Messenger RNA
51%
Formaldehyde
50%
Gene Expression
48%
Intravascular Ultrasound
46%
Magnetic Resonance Imaging
46%
Heart Function
46%
Restenosis
46%
Left Coronary Artery
46%
Extracellular Trap
46%
Adenocarcinoma
46%
Fetus Echography
46%
Androgen Deprivation Therapy
46%
Salivary Duct Carcinoma
46%
Aortitis
46%
Keratin 13
46%
Cholesteatoma
46%
Keratin 17
46%
Cell Transdifferentiation
46%
Papillary Thyroid Cancer
46%
Rotator Cuff Rupture
46%
Coronary Reperfusion
46%
Epithelial-Myoepithelial Carcinoma
46%
Gastritis
46%
in Situ Hybridization
46%
Stomach Cancer
46%
Transcatheter Therapy
46%
Surgical Anastomosis
46%
Echography
46%
Coronary Artery Dilatation
46%
Bronchial Artery
46%
Heart-Type Fatty Acid Binding Protein
46%
Thorax Pain
46%
Myoglobin
46%
Chromatin Remodeling
46%
Finger
46%
Cell Death
46%
Fingertip
46%
Hemoglobin A1c
46%
Coronary Computed Tomography Angiography
46%
Vascular Bundle
46%
Capillary
46%
Puncture
46%
Booster Dose
46%
COVID-19
46%
Heart Failure with Preserved Ejection Fraction
46%
Cardiac Sarcoidosis
46%
Coronary Artery Disease
46%
Neuroendocrine Tumor
46%
Hepatitis B Antigen
46%
D-Dimer
46%
Cardiovascular Disease
46%
Heart Failure with Reduced Ejection Fraction
46%
Hepatocyte
46%
Cancer Growth
46%
Unfolded Protein Response
46%
Cancer
38%
Epithelioma
37%
Vein Puncture
37%
Endoplasmic Reticulum Stress
33%
Familial Adenomatous Polyposis
31%
Cancer Cell
31%
Adenoma
28%
Mucin 5AC
28%
Lung Adenocarcinoma
28%
Malignant Neoplasm
24%
Small Cell Lung Cancer
24%
Neuroendocrine Carcinoma
24%
Aortic Insufficiency
23%
Epithelial Cell
23%
Vascular Lesion
23%
Prostate Adenocarcinoma
23%
Heart Left Ventricle Ejection Fraction
23%
Liver Injury
21%
Cell Viability
20%
Tissue Microarray
20%
Kidney Function
19%
Angioscopy
18%
Mucin 6
18%
C Reactive Protein
18%
Platelet
18%
Blood Cell
18%
Hepatitis B Virus
16%
Bleeding
15%
Testes
15%
Microscopy
15%
Bronchiole
15%
Cancer Cell Line
15%
Thyroid Carcinoma
15%
Fine-Needle Aspiration
15%
Prostate Cancer
15%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Injury
100%
Brain Natriuretic Peptide
93%
Spermidine
93%
Low Density Lipoprotein Cholesterol
93%
Vaccination Policy
80%
Cardiovascular Disease
80%
Mouse
77%
Hepatitis B Virus
73%
Biological Marker
67%
Heart Failure
64%
Hepatitis B Antigen
63%
Concanavalin A
60%
Receptor
53%
Interferon
53%
SARS Coronavirus
53%
Acute Heart Failure
51%
Messenger RNA
51%
D Dimer
50%
Stenosis
46%
Androgen Receptor
46%
Ribavirin
46%
Hyalin
46%
Restenosis
46%
Canagliflozin
46%
Febuxostat
46%
Sodium Glucose Cotransporter 2 Inhibitor
46%
Sitagliptin
46%
Mouth Cancer
46%
Short Chain Fatty Acid
46%
Cytokeratin 18
46%
Lactoferrin
46%
Myoglobin
46%
Creatine Kinase Isoenzyme
46%
Binding Protein
46%
Nonalcoholic Fatty Liver
46%
Liver Fibrosis
46%
Fibrinolytic Agent
46%
Peginterferon
46%
Chronic Hepatitis C
46%
Prostate Cancer
46%
Stomach Cancer
46%
Genotoxicity
46%
Omega 3 Acid Ethyl Ester
46%
Pitavastatin
46%
Statin (Protein)
46%
Coronary Artery Disease
46%
Immunogenicity
46%
Adjuvant
46%
Cancer Growth
46%
Mannose
46%
Immunoglobulin G Antibody
46%
Neuroendocrine Tumor
46%
Long Untranslated RNA
46%
Hemoglobin A1c
46%
Heart Failure with Preserved Ejection Fraction
46%
Cardiovascular Risk
46%
Vaccine
46%
Heart Failure with Reduced Ejection Fraction
46%
Autoimmune Hepatitis
46%
Coronavirinae
38%
Disease
38%
Transgenic Mouse
26%
Antiviral Therapy
23%
Intestine Flora
23%
ELISA Sandwich
23%
Chromogenic Substrate
23%
C Reactive Protein
23%
Transcriptome
21%
Mouse Model
19%
Gout
18%
Malignant Neoplasm
18%
4-Aminobiphenyl
18%
Triacylglycerol
18%
Urinary Cast
15%
Abscess
15%
Fibrin
15%
Urokinase
15%
Neoplasm
15%
Castration Resistant Prostate Cancer
14%
Lupus Anticoagulant
14%
Galactosylceramide
13%
Vaccine Adjuvant
13%
Adenosine Phosphate
13%
Cyclic GMP
13%
Fatty Liver
12%
Dipeptidyl Peptidase IV
12%
Adiponectin
12%
Leptin
12%
Population Study
12%
Lung Adenocarcinoma
12%
Coronary Artery Obstruction
11%
Hepatitis C
11%
Aminotransferase
11%
Creatinine
11%
Bleeding
11%
Infection
9%
Epileptic Absence
9%
Histone H2AX
9%
Small Cell Lung Cancer
9%
Neuroendocrine Carcinoma
9%